KL16-012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KL16-012, covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment. [Phase 2]